Grade 2 and 3 Late Xerostomia Caused by Radiotherapy for Cancers of the Upper Aerodigestive Tract, Excluding the Parotid Glands
Oncology
2
Pipeline Programs
1
Companies
2
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
MeiraGTxNEW YORK, NY
2 programs2
AAV2-hAQP1Phase 21 trial
AAV2-hAQP1 Concentration 1Phase 21 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
2027
2028
2029
2030
2031
MeiraGTxAAV2-hAQP1
MeiraGTxAAV2-hAQP1 Concentration 1
Clinical Trials (2)
Long-term Follow-up of Gene Therapy for Radiation-Induced Xerostomia
Start: Aug 2024Est. completion: Feb 2032
Phase 2Enrolling By Invitation
A Study of AAV2-hAQP1 Gene Therapy in Participants With Radiation-Induced Late Xerostomia
Start: Jun 2023Est. completion: Dec 2026
Phase 2Recruiting
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
13m ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
13m ago
Office Administrator
SystImmune
13m ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
24m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
27m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
27m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials
1 companies competing in this space